First, do no (irreparable) harm: infarction, bleeding, and subsequent risk of death. The dangers of false equivalency
- PMID: 28363223
- DOI: 10.1093/eurheartj/ehw639
First, do no (irreparable) harm: infarction, bleeding, and subsequent risk of death. The dangers of false equivalency
Comment on
-
Trade-off of myocardial infarction vs. bleeding types on mortality after acute coronary syndrome: lessons from the Thrombin Receptor Antagonist for Clinical Event Reduction in Acute Coronary Syndrome (TRACER) randomized trial.Eur Heart J. 2017 Mar 14;38(11):804-810. doi: 10.1093/eurheartj/ehw525. Eur Heart J. 2017. PMID: 28363222 Free PMC article. Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
